| 000 | 01539 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250516200402.0 | ||
| 264 | 0 | _c20141125 | |
| 008 | 201411s 0 0 eng d | ||
| 022 | _a1432-1041 | ||
| 024 | 7 |
_a10.1007/s00228-014-1654-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Zexing | |
| 245 | 0 | 0 |
_aMultitargeted antiangiogenic tyrosine kinase inhibitors combined to chemotherapy in metastatic breast cancer: a systematic review and meta-analysis. _h[electronic resource] |
| 260 |
_bEuropean journal of clinical pharmacology _cMay 2014 |
||
| 300 |
_a531-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aBreast Neoplasms _xblood supply |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 700 | 1 | _aWang, Meiqi | |
| 700 | 1 | _aYang, Fei | |
| 700 | 1 | _aNie, Weiwei | |
| 700 | 1 | _aChen, Fengxia | |
| 700 | 1 | _aXu, Jing | |
| 700 | 1 | _aGuan, Xiaoxiang | |
| 773 | 0 |
_tEuropean journal of clinical pharmacology _gvol. 70 _gno. 5 _gp. 531-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00228-014-1654-5 _zAvailable from publisher's website |
| 999 |
_c23579449 _d23579449 |
||